Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels

Magdolna Szántó, Attila Brunyánszki, I. Márton, G. Vámosi, Lilla Nagy, Tamás Fodor, Borbála Kiss, L. Virag, P. Gergely, P. Bai

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Poly(ADP-ribose) polymerase-2 (PARP-2) is acknowledged as a DNA repair enzyme. However, recent investigations have attributed unique roles to PARP-2 in metabolic regulation in the liver. We assessed changes in hepatic lipid homeostasis upon the deletion of PARP-2 and found that cholesterol levels were higher in PARP-2-/- mice as compared to wild-type littermates. To uncover the molecular background, we analyzed changes in steady-state mRNA levels upon the knockdown of PARP-2 in HepG2 cells and in murine liver that revealed higher expression of sterol-regulatory element binding protein (SREBP)-1 dependent genes. We demonstrated that PARP-2 is a suppressor of the SREBP1 promoter, and the suppression of the SREBP1 gene depends on the enzymatic activation of PARP-2. Consequently, the knockdown of PARP-2 enhances SREBP1 expression that in turn induces the genes driven by SREBP1 culminating in higher hepatic cholesterol content. We did not detect hypercholesterolemia, higher fecal cholesterol content or increase in serum LDL, although serum HDL levels decreased in the PARP-2-/- mice. In cells and mice where PARP-2 was deleted we observed decreased ABCA1 mRNA and protein expression that is probably linked to lower HDL levels. In our current study we show that PARP-2 impacts on hepatic and systemic cholesterol homeostasis. Furthermore, the depletion of PARP-2 leads to lower HDL levels which represent a risk factor to cardiovascular diseases.

Original languageEnglish
Pages (from-to)594-602
Number of pages9
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1842
Issue number4
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Poly(ADP-ribose) Polymerases
Cholesterol
Liver
Hypercholesterolemia
ATP Binding Cassette Transporter 1
Homeostasis
Sterol Regulatory Element Binding Protein 1
DNA Repair Enzymes
Genes
Messenger RNA
Hep G2 Cells
Serum
Cardiovascular Diseases
Lipids

Keywords

  • ABCA1
  • Cholesterol
  • HDL
  • Lipoprotein
  • PARP-2
  • SREBP1

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels. / Szántó, Magdolna; Brunyánszki, Attila; Márton, I.; Vámosi, G.; Nagy, Lilla; Fodor, Tamás; Kiss, Borbála; Virag, L.; Gergely, P.; Bai, P.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, No. 4, 04.2014, p. 594-602.

Research output: Contribution to journalArticle

@article{cc4a2d63cd4e415699159deafd312322,
title = "Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels",
abstract = "Poly(ADP-ribose) polymerase-2 (PARP-2) is acknowledged as a DNA repair enzyme. However, recent investigations have attributed unique roles to PARP-2 in metabolic regulation in the liver. We assessed changes in hepatic lipid homeostasis upon the deletion of PARP-2 and found that cholesterol levels were higher in PARP-2-/- mice as compared to wild-type littermates. To uncover the molecular background, we analyzed changes in steady-state mRNA levels upon the knockdown of PARP-2 in HepG2 cells and in murine liver that revealed higher expression of sterol-regulatory element binding protein (SREBP)-1 dependent genes. We demonstrated that PARP-2 is a suppressor of the SREBP1 promoter, and the suppression of the SREBP1 gene depends on the enzymatic activation of PARP-2. Consequently, the knockdown of PARP-2 enhances SREBP1 expression that in turn induces the genes driven by SREBP1 culminating in higher hepatic cholesterol content. We did not detect hypercholesterolemia, higher fecal cholesterol content or increase in serum LDL, although serum HDL levels decreased in the PARP-2-/- mice. In cells and mice where PARP-2 was deleted we observed decreased ABCA1 mRNA and protein expression that is probably linked to lower HDL levels. In our current study we show that PARP-2 impacts on hepatic and systemic cholesterol homeostasis. Furthermore, the depletion of PARP-2 leads to lower HDL levels which represent a risk factor to cardiovascular diseases.",
keywords = "ABCA1, Cholesterol, HDL, Lipoprotein, PARP-2, SREBP1",
author = "Magdolna Sz{\'a}nt{\'o} and Attila Bruny{\'a}nszki and I. M{\'a}rton and G. V{\'a}mosi and Lilla Nagy and Tam{\'a}s Fodor and Borb{\'a}la Kiss and L. Virag and P. Gergely and P. Bai",
year = "2014",
month = "4",
doi = "10.1016/j.bbadis.2013.12.006",
language = "English",
volume = "1842",
pages = "594--602",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels

AU - Szántó, Magdolna

AU - Brunyánszki, Attila

AU - Márton, I.

AU - Vámosi, G.

AU - Nagy, Lilla

AU - Fodor, Tamás

AU - Kiss, Borbála

AU - Virag, L.

AU - Gergely, P.

AU - Bai, P.

PY - 2014/4

Y1 - 2014/4

N2 - Poly(ADP-ribose) polymerase-2 (PARP-2) is acknowledged as a DNA repair enzyme. However, recent investigations have attributed unique roles to PARP-2 in metabolic regulation in the liver. We assessed changes in hepatic lipid homeostasis upon the deletion of PARP-2 and found that cholesterol levels were higher in PARP-2-/- mice as compared to wild-type littermates. To uncover the molecular background, we analyzed changes in steady-state mRNA levels upon the knockdown of PARP-2 in HepG2 cells and in murine liver that revealed higher expression of sterol-regulatory element binding protein (SREBP)-1 dependent genes. We demonstrated that PARP-2 is a suppressor of the SREBP1 promoter, and the suppression of the SREBP1 gene depends on the enzymatic activation of PARP-2. Consequently, the knockdown of PARP-2 enhances SREBP1 expression that in turn induces the genes driven by SREBP1 culminating in higher hepatic cholesterol content. We did not detect hypercholesterolemia, higher fecal cholesterol content or increase in serum LDL, although serum HDL levels decreased in the PARP-2-/- mice. In cells and mice where PARP-2 was deleted we observed decreased ABCA1 mRNA and protein expression that is probably linked to lower HDL levels. In our current study we show that PARP-2 impacts on hepatic and systemic cholesterol homeostasis. Furthermore, the depletion of PARP-2 leads to lower HDL levels which represent a risk factor to cardiovascular diseases.

AB - Poly(ADP-ribose) polymerase-2 (PARP-2) is acknowledged as a DNA repair enzyme. However, recent investigations have attributed unique roles to PARP-2 in metabolic regulation in the liver. We assessed changes in hepatic lipid homeostasis upon the deletion of PARP-2 and found that cholesterol levels were higher in PARP-2-/- mice as compared to wild-type littermates. To uncover the molecular background, we analyzed changes in steady-state mRNA levels upon the knockdown of PARP-2 in HepG2 cells and in murine liver that revealed higher expression of sterol-regulatory element binding protein (SREBP)-1 dependent genes. We demonstrated that PARP-2 is a suppressor of the SREBP1 promoter, and the suppression of the SREBP1 gene depends on the enzymatic activation of PARP-2. Consequently, the knockdown of PARP-2 enhances SREBP1 expression that in turn induces the genes driven by SREBP1 culminating in higher hepatic cholesterol content. We did not detect hypercholesterolemia, higher fecal cholesterol content or increase in serum LDL, although serum HDL levels decreased in the PARP-2-/- mice. In cells and mice where PARP-2 was deleted we observed decreased ABCA1 mRNA and protein expression that is probably linked to lower HDL levels. In our current study we show that PARP-2 impacts on hepatic and systemic cholesterol homeostasis. Furthermore, the depletion of PARP-2 leads to lower HDL levels which represent a risk factor to cardiovascular diseases.

KW - ABCA1

KW - Cholesterol

KW - HDL

KW - Lipoprotein

KW - PARP-2

KW - SREBP1

UR - http://www.scopus.com/inward/record.url?scp=84893489225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893489225&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2013.12.006

DO - 10.1016/j.bbadis.2013.12.006

M3 - Article

C2 - 24365238

AN - SCOPUS:84893489225

VL - 1842

SP - 594

EP - 602

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 4

ER -